These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34662226)

  • 21. Comparative Analysis of the Capsid Structures of AAVrh.10, AAVrh.39, and AAV8.
    Mietzsch M; Barnes C; Hull JA; Chipman P; Xie J; Bhattacharya N; Sousa D; McKenna R; Gao G; Agbandje-McKenna M
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31826994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system.
    Burger C; Gorbatyuk OS; Velardo MJ; Peden CS; Williams P; Zolotukhin S; Reier PJ; Mandel RJ; Muzyczka N
    Mol Ther; 2004 Aug; 10(2):302-17. PubMed ID: 15294177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adeno-associated virus serotypes for gene therapeutics.
    Lisowski L; Tay SS; Alexander IE
    Curr Opin Pharmacol; 2015 Oct; 24():59-67. PubMed ID: 26291407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids.
    Castle MJ; Turunen HT; Vandenberghe LH; Wolfe JH
    Methods Mol Biol; 2016; 1382():133-49. PubMed ID: 26611584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy.
    Choudhury SR; Fitzpatrick Z; Harris AF; Maitland SA; Ferreira JS; Zhang Y; Ma S; Sharma RB; Gray-Edwards HL; Johnson JA; Johnson AK; Alonso LC; Punzo C; Wagner KR; Maguire CA; Kotin RM; Martin DR; Sena-Esteves M
    Mol Ther; 2016 Aug; 24(7):1247-57. PubMed ID: 27117222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tailoring the AAV vector capsid for gene therapy.
    Vandenberghe LH; Wilson JM; Gao G
    Gene Ther; 2009 Mar; 16(3):311-9. PubMed ID: 19052631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rational design and engineering of a modified adeno-associated virus (AAV1)-based vector system for enhanced retrograde gene delivery.
    Davis AS; Federici T; Ray WC; Boulis NM; OʼConnor D; Clark KR; Bartlett JS
    Neurosurgery; 2015 Feb; 76(2):216-25; discussion 225. PubMed ID: 25549186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetically Engineered Adeno-Associated Virus for Efficient, Safe, and Versatile Gene Therapy Applications.
    Lugin ML; Lee RT; Kwon YJ
    ACS Nano; 2020 Nov; 14(11):14262-14283. PubMed ID: 33073995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adeno-associated virus as a gene therapy vector: strategies to neutralize the neutralizing antibodies.
    Lotfinia M; Abdollahpour-Alitappeh M; Hatami B; Zali MR; Karimipoor M
    Clin Exp Med; 2019 Aug; 19(3):289-298. PubMed ID: 31054018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic Engineering of AAV Capsid Gene for Gene Therapy Application.
    Liu Y; Zhang X; Yang L
    Curr Gene Ther; 2020; 20(5):321-332. PubMed ID: 32998676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the Adeno-Associated Virus 1 and 6 Sialic Acid Binding Site.
    Huang LY; Patel A; Ng R; Miller EB; Halder S; McKenna R; Asokan A; Agbandje-McKenna M
    J Virol; 2016 Jun; 90(11):5219-5230. PubMed ID: 26962225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Lung Tropic Adeno-Associated Virus Capsids for Therapeutic Gene Delivery.
    Carneiro A; Lee H; Lin L; van Haasteren J; Schaffer DV
    Hum Gene Ther; 2020 Sep; 31(17-18):996-1009. PubMed ID: 32799685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptor targeting of adeno-associated virus vectors.
    Büning H; Ried MU; Perabo L; Gerner FM; Huttner NA; Enssle J; Hallek M
    Gene Ther; 2003 Jul; 10(14):1142-51. PubMed ID: 12833123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adeno-associated virus (AAV) vectors in cancer gene therapy.
    Santiago-Ortiz JL; Schaffer DV
    J Control Release; 2016 Oct; 240():287-301. PubMed ID: 26796040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of capsid modifications by selected peptide ligands on recombinant adeno-associated virus serotype 2-mediated gene transduction.
    Naumer M; Popa-Wagner R; Kleinschmidt JA
    J Gen Virol; 2012 Oct; 93(Pt 10):2131-2141. PubMed ID: 22764318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells.
    Shayakhmetov DM; Carlson CA; Stecher H; Li Q; Stamatoyannopoulos G; Lieber A
    J Virol; 2002 Feb; 76(3):1135-43. PubMed ID: 11773389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent Advances in the Analysis Full/Empty Capsid Ratio and Genome Integrity of Adeno-associated Virus (AAV) Gene Delivery Vectors.
    Hajba L; Guttman A
    Curr Mol Med; 2020; 20(10):806-813. PubMed ID: 32748744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Widespread Central Nervous System Gene Transfer and Silencing After Systemic Delivery of Novel AAV-AS Vector.
    Choudhury SR; Harris AF; Cabral DJ; Keeler AM; Sapp E; Ferreira JS; Gray-Edwards HL; Johnson JA; Johnson AK; Su Q; Stoica L; DiFiglia M; Aronin N; Martin DR; Gao G; Sena-Esteves M
    Mol Ther; 2016 Apr; 24(4):726-35. PubMed ID: 26708003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineered Capsids for Efficient Gene Delivery to the Retina and Cornea.
    Frederick A; Sullivan J; Liu L; Adamowicz M; Lukason M; Raymer J; Luo Z; Jin X; Rao KN; O'Riordan C
    Hum Gene Ther; 2020 Jul; 31(13-14):756-774. PubMed ID: 32578442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector.
    Bowles DE; McPhee SW; Li C; Gray SJ; Samulski JJ; Camp AS; Li J; Wang B; Monahan PE; Rabinowitz JE; Grieger JC; Govindasamy L; Agbandje-McKenna M; Xiao X; Samulski RJ
    Mol Ther; 2012 Feb; 20(2):443-55. PubMed ID: 22068425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.